socaltech | Shared With: Everyone - Oct 04 2006 | prolacta, venture, capital, vc, investment, socaltechMonrovia-based Prolacta Bioscience has raised $5M, in a Series B prime financing round. The firm said that the funding came from Arcturus Capital, DFJ Mercury, Philip Capital, Funk Ventures Capital, and the Gideon Hixon Fund, along with existing investors
Related Content from Around Faves
investment
-
This is not too surprising given Japan's dependency on U.S. consumers.
Let's see how this affects the U.S. markets tomorrow.
1 FaverViewed: 3 TimesQuoted: Japan’s economy has been hurt by weak export growth and steep cuts in corporate spending amid the worsening global slowdown.
- ClaraSet - 17 hours ago7 Favers
- ClaraSet - 21 hours ago3 Favers
